Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer

Because of its proven efficacy, intravesical Bacillus Calmette-Guérin (BCG) immunotherapy is an important treatment for nonmuscle invasive bladder cancer at high risk of recurrence or progression. However, approximately 8% of patients have to stop BCG instillation as a result of its complications. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuqing, Lu, Jian, Huang, Yi, Ma, Lulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431507/
https://www.ncbi.nlm.nih.gov/pubmed/30984262
http://dx.doi.org/10.1155/2019/6230409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431507/
https://www.ncbi.nlm.nih.gov/pubmed/30984262
http://dx.doi.org/10.1155/2019/6230409

Ejemplares similares